NovoEight IV 500 (YJ code: 6343440D2020, 500 IU x 1 bottle (with dissolving liquid)), manufactured by Novo Nordisk Pharma, contains Turoctocog alpha (genetically recombination). This recombinant Factor VIII is used for both the treatment and prophylaxis of bleeding in individuals with hemophilia A.
NovoEight IV 500
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →